162 related articles for article (PubMed ID: 17975143)
1. MCP-1 Promoter Polymorphism at 2518 is associated with metastasis of nasopharyngeal carcinoma after treatment.
Tse KP; Tsang NM; Chen KD; Li HP; Liang Y; Hsueh C; Chang KP; Yu JS; Hao SP; Hsieh LL; Chang YS
Clin Cancer Res; 2007 Nov; 13(21):6320-6. PubMed ID: 17975143
[TBL] [Abstract][Full Text] [Related]
2. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with psoriasis.
Wang L; Yang L; Gao L; Gao TW; Li W; Liu YF
Int J Immunogenet; 2008 Feb; 35(1):45-9. PubMed ID: 18093183
[TBL] [Abstract][Full Text] [Related]
3. Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival.
Liao WT; Song LB; Zhang HZ; Zhang X; Zhang L; Liu WL; Feng Y; Guo BH; Mai HQ; Cao SM; Li MZ; Qin HD; Zeng YX; Zeng MS
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):508-14. PubMed ID: 17255272
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic impact of plasma Epstein-Barr virus DNA concentration on distant metastasis in nasopharyngeal carcinoma].
Hou X; Zhang L; Zhao C; Li S; Lu LX; Han F; Shao JY; Huang PY
Ai Zheng; 2006 Jul; 25(7):785-92. PubMed ID: 16831265
[TBL] [Abstract][Full Text] [Related]
5. [Correlation of pretreatment serum level of endostatin to posttreatment distant metastasis in patients with advanced nasopharyngeal carcinoma].
Zhao ZJ; Mo HY; Zhang CQ; Qi B; Li J; Hong MH; Mai HQ
Ai Zheng; 2007 Nov; 26(11):1243-7. PubMed ID: 17991326
[TBL] [Abstract][Full Text] [Related]
6. Association of IL-8 (-251)T/A polymorphism with susceptibility to and aggressiveness of nasopharyngeal carcinoma.
Ben Nasr H; Chahed K; Mestiri S; Bouaouina N; Snoussi K; Chouchane L
Hum Immunol; 2007 Sep; 68(9):761-9. PubMed ID: 17869651
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas.
Nasr HB; Mestiri S; Chahed K; Bouaouina N; Gabbouj S; Jalbout M; Chouchane L
Clin Chim Acta; 2007 Sep; 384(1-2):57-63. PubMed ID: 17599818
[TBL] [Abstract][Full Text] [Related]
8. The prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma.
Lee CC; Chu ST; Chou P; Lee CC; Chen LF
Clin Otolaryngol; 2008 Oct; 33(5):442-9. PubMed ID: 18983377
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between VEGF-C expression and nasopharyngeal carcinoma proliferation and metastasis].
Shi XY; Hu GQ; Yuan XL; Li HY; Liu YQ; Ma D
Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):364-7. PubMed ID: 17045002
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of high mobility group box 1 (HMGB1) is associated with progression and poor prognosis in human nasopharyngeal carcinoma.
Wu D; Ding Y; Wang S; Zhang Q; Liu L
J Pathol; 2008 Oct; 216(2):167-75. PubMed ID: 18680137
[TBL] [Abstract][Full Text] [Related]
11. The AA genotype of the regulatory BCL2 promoter polymorphism ( 938C>A) is associated with a favorable outcome in lymph node negative invasive breast cancer patients.
Bachmann HS; Otterbach F; Callies R; Nückel H; Bau M; Schmid KW; Siffert W; Kimmig R
Clin Cancer Res; 2007 Oct; 13(19):5790-7. PubMed ID: 17908970
[TBL] [Abstract][Full Text] [Related]
12. The 30-bp deletion of Epstein-Barr virus latent membrane protein-1 gene has no effect in nasopharyngeal carcinoma.
Chang KP; Hao SP; Lin SY; Ueng SH; Pai PC; Tseng CK; Hsueh C; Hsieh MS; Yu JS; Tsang NM
Laryngoscope; 2006 Apr; 116(4):541-6. PubMed ID: 16585856
[TBL] [Abstract][Full Text] [Related]
13. Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma: prognostic value and staging categories.
Ma J; Liu L; Tang L; Zong J; Lin A; Lu T; Cui N; Cui C; Li L
Clin Cancer Res; 2007 Mar; 13(5):1445-52. PubMed ID: 17332287
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI
Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741
[TBL] [Abstract][Full Text] [Related]
15. Macrophage inflammatory protein-3alpha is a novel serum marker for nasopharyngeal carcinoma detection and prediction of treatment outcomes.
Chang KP; Hao SP; Chang JH; Wu CC; Tsang NM; Lee YS; Hsu CL; Ueng SH; Liu SC; Liu YL; Wei PC; Liang Y; Chang YS; Yu JS
Clin Cancer Res; 2008 Nov; 14(21):6979-87. PubMed ID: 18980993
[TBL] [Abstract][Full Text] [Related]
16. Association of IL-1B gene polymorphisms with nasopharyngeal carcinoma in a Chinese population.
Zhu Y; Xu Y; Wei Y; Liang W; Liao M; Zhang L
Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):207-11. PubMed ID: 18289837
[TBL] [Abstract][Full Text] [Related]
17. A single nucleotide polymorphism in the E-cadherin gene promoter -160 C/A is associated with risk of nasopharyngeal cancer.
Ben Nasr H; Hamrita B; Batbout M; Gabbouj S; Bouaouina N; Chouchane L; Chahed K
Clin Chim Acta; 2010 Sep; 411(17-18):1253-7. PubMed ID: 20462505
[TBL] [Abstract][Full Text] [Related]
18. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma.
Li YH; Hu CF; Shao Q; Huang MY; Hou JH; Xie D; Zeng YX; Shao JY
J Transl Med; 2008 Jan; 6():1. PubMed ID: 18171482
[TBL] [Abstract][Full Text] [Related]
19. Functional vascular endothelial growth factor -2578 C/A polymorphism in relation to nasopharyngeal carcinoma risk and tumor progression.
Nasr HB; Chahed K; Bouaouina N; Chouchane L
Clin Chim Acta; 2008 Sep; 395(1-2):124-9. PubMed ID: 18588866
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of bcl-2 expression on advanced nasopharyngeal carcinoma.
Chen MK; Lai JC; Chang CC; Chang JH; Chang YJ; Chen HC
Head Neck; 2008 Aug; 30(8):1052-7. PubMed ID: 18442057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
